These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26073482)

  • 1. Posterior reversible encephalopathy syndrome treated with renin-angiotensin system blockade.
    Mishima E; Hashimoto J; Akiyama Y; Seiji K; Takase K; Abe T; Ito S
    J Neurol Sci; 2015 Aug; 355(1-2):219-21. PubMed ID: 26073482
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of renin-angiotensin-aldosterone system blockades for acute phase hypertensive emergencies in patient complicating severe acute kidney injury.
    Watanabe K; Hamada T; Shimada K; Fujimaru T; Ito Y; Nagahama M; Taki F; Nakayama M
    CEN Case Rep; 2022 Feb; 11(1):105-109. PubMed ID: 34420196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment of combination therapy using an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker in a patient with IgA nephropathy].
    Horino T; Ito H; Tanimoto N; Yoshida T; Sasaoka A; Chijiwa T; Hosokawa T; Hashimoto K
    Nihon Jinzo Gakkai Shi; 2003; 45(2):104-8. PubMed ID: 12703406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors.
    Mercier K; Smith H; Biederman J
    Prim Care; 2014 Dec; 41(4):765-78. PubMed ID: 25439533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Essential hypertension and natriuretic peptides].
    Kanmatsuse K; Fujita H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():110-2. PubMed ID: 15506350
    [No Abstract]   [Full Text] [Related]  

  • 6. [How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system].
    Schleich F; Krzesinski JM; Piérard L; Scheen AJ
    Rev Med Liege; 2008 Apr; 63(4):174-81. PubMed ID: 18575070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basiliximab for posterior reversible encephalopathy syndrome after lung transplantation.
    Yamagishi H; Chen-Yoshikawa TF; Date H
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):823-824. PubMed ID: 28498905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: observations from Val-HeFT and CALM.
    Chin BS; Lip GY
    J Hum Hypertens; 2001 Feb; 15(2):89-92. PubMed ID: 11317186
    [No Abstract]   [Full Text] [Related]  

  • 9. Renin-angiotensin system and cardiovascular risk.
    Schmieder RE; Hilgers KF; Schlaich MP; Schmidt BM
    Lancet; 2007 Apr; 369(9568):1208-19. PubMed ID: 17416265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus.
    Parving HH
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):30-1. PubMed ID: 11967794
    [No Abstract]   [Full Text] [Related]  

  • 11. Sustained 24-hour blockade of the renin-angiotensin system: a high dose of a long-acting blocker is as effective as a lower dose combined with an angiotensin-converting enzyme inhibitor.
    Hasler C; Nussberger J; Maillard M; Forclaz A; Brunner HR; Burnier M
    Clin Pharmacol Ther; 2005 Nov; 78(5):501-7. PubMed ID: 16321616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.
    Anderson C; Teo K; Gao P; Arima H; Dans A; Unger T; Commerford P; Dyal L; Schumacher H; Pogue J; Paolasso E; Holwerda N; Chazova I; Binbrek A; Young J; Yusuf S;
    Lancet Neurol; 2011 Jan; 10(1):43-53. PubMed ID: 20980201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
    Middeke M
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
    [No Abstract]   [Full Text] [Related]  

  • 15. The renin-angiotensin-aldosterone system and heart failure.
    Sayer G; Bhat G
    Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-atherosclerotic action of ACE inhibitors. I. Inactivation of the renin-angiotensin system].
    Stajszczyk M; Gmiński J
    Postepy Hig Med Dosw; 1996; 50(2):157-71. PubMed ID: 8848424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of renin-angiotensin system blockade on macrophage infiltration in patients with hypertensive nephrosclerosis.
    Imakiire T; Kikuchi Y; Yamada M; Kushiyama T; Higashi K; Hyodo N; Yamamoto K; Oda T; Suzuki S; Miura S
    Hypertens Res; 2007 Jul; 30(7):635-42. PubMed ID: 17785932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
    Weinberg MS; Weinberg AJ; Zappe DH
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
    [No Abstract]   [Full Text] [Related]  

  • 19. [The renin-angiotensin system:implications, pathology, therapeutic possibilities, perspectives].
    Ionescu SD; Sandru V; Burdujan A; Tovarniţchi S
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):669-73. PubMed ID: 12092217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
    Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
    Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.